Biotechnology News

May 8, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--David Allan, founding Chairman of YM BioSciences and its 13-year CEO is being recognized by the industry in BIOTECanada’s naming him as recipient of the Gold Leaf Award for Industry Leadership.

May 8, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a...

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies, today announced the addition of George Demetri, M.D.,...

May 8, 2012

BOSTON--(BUSINESS WIRE)--Partnering to acquire key capabilities like local market knowledge, access, networks & government support is the most important factor for formulation and delivery players, according to Lux Research.

May 8, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA [OSL:DIAG] have received grants of world-wide trademark for key brand names in the DiaGenic portfolio: ADtect®, MCItect®, PDtect® and BCtect®. Trademark protection adds to building a...

May 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is announcing their participation at the Bank of America 2012 Health Care Conference on Tuesday, May 15th.

May 8, 2012

PARIS--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will unveil its new OneShot™ renal denervation system at the EuroPCR congress in Paris, France, on May 16, 2012.

May 8, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the first quarter ended March 31, 2012. Quarter and Recent Highlights Increased total revenue 92% and product revenue 78% to $6...

May 8, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis enrolls patients in CRUK Phase 1/2 trial in head and neck cancer

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Secured $20 million and expanded Series A financing with an additional investor, Jafco Co., Ltd, proceeds to advance, EBI-005, into clinic development for dry eye disease

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics presents data at ARVO demonstrating optimal properties of EBI-005, first rationally-designed, IL-1 inhibitor protein for topical administration optimized for ocular disorders.

May 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today provided a Company update and reported financial results for the first quarter of 2012. “Our team successfully addressed FDA’s concerns about Capesaris, and we expect to initiate our...

May 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that the Food and Drug Administration (FDA) removed its Full Clinical Hold on the Company’s Investigational New Drug application for Capesaris® following the review by the...

May 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the following presentations by Company management at upcoming investor...

May 8, 2012

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin”, the “Company”, “us” or “our”) , a technology-focused supplier of hybrid and genetically modified crop seeds in China, today announced unaudited financial results for the...

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on...

May 8, 2012

SEATTLE--(BUSINESS WIRE)--In collaboration with the University of Washington and the University of Texas Medical Branch at Galveston, Seattle-based biotech company, Kineta, Inc. announced a new $8.1 million biodefense grant to develop new drugs...

May 8, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA (OSE:DIAG): DiaGenic today reports on the finalization of data collection and database lock of a blinded study in a Norwegian cohort of 80 patients with familial Parkinson’s disease (PD...

May 8, 2012

BURTON-ON-TRENT, England--(BUSINESS WIRE)--Clinigen's sNDA for Foscavir approved by the US FDA

May 7, 2012

WASHINGTON--(BUSINESS WIRE)--Allied advanced biofuel, airline and farm groups today sent letters to Congressional Armed Services and Appropriations committees urging support for military biofuels in legislative markups this week.

May 7, 2012

CARLSBAD, Calif. & SUZHOU, China--(BUSINESS WIRE)--The international biotech and pharma community will converge upon the city of Suzhou, China, a rapidly growing base for life science industries, at ChinaBio® Partnering Forum 2012 on May 23...

May 7, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for...

May 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., today announced an agreement to provide Next Generation Sequencing (NGS) sample preparation solutions to Macrogen, Inc., a Korean-based global sequencing company.

May 7, 2012

SEATTLE--(BUSINESS WIRE)--May 7, 2012--Dendreon Corporation (Nasdaq:DNDN) today reported results for the quarter ended March 31, 2012. Net product revenue for the quarter was $82.0 million compared to $27.0 million for the quarter ended March 31...

May 7, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Baird 2012 Growth Stock Conference in Chicago, Illinois on Wednesday, May 9th, at 10:05 a.m. CDT (11:05 a.m...

May 7, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the company will be...

May 7, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company, today announced financial and business results for the quarter ended March 31, 2012. First Quarter 2012 Financial Results Maxygen reported a net loss...

May 7, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the first quarter ended March 31, 2012 and other business updates. Total product revenue was $171.1 million for the...

May 7, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today reported financial results for the first quarter ended March 31, 2012. The net income for the first quarter of 2012 was $31.5 million (or $0.87 per share) compared to a net...

May 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May...

May 7, 2012

NEW YORK--(BUSINESS WIRE)--“OneMedForum NY2012” To Feature Expert Panels, Investor Guides and Disruptive Technologies from Emerging Companies

May 7, 2012

JUPITER, Fla.--(BUSINESS WIRE)--Envoy has been awarded a second grant from The Michael J. Fox Foundation (MJFF) to continue development of compounds that selectively act on the motor circuitry that is compromised in Parkinson's.

May 7, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Clinverse receives $3.8 M to expand its financial technology for clinical trials; will support customer expansion of biopharma’s only cloud-based investigator site payment ecommerce platform.

May 7, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--The Competitive Landscape Seminar Series: Market Access, is a one-day seminar that will be held in New York City on May 17, 2012 addressing healthcare market access drivers and opportunities. The seminar will...

May 7, 2012

BOSTON--(BUSINESS WIRE)--H&Q Healthcare Investors and H&Q Life Sciences Investors announced with profound sadness the death of Lawrence S. Lewin, Chairman of the Board of Trustees of each Fund. Mr. Lewin died on Sunday, April 29th, after...

May 7, 2012

CANDIAC, Quebec--(BUSINESS WIRE)--Cascades Tissue Group, applauds the third annual “STOP! Clean Your Hands Day,” May 7, which is also a good time to note that paper towels are the most hygienic choice when it comes to drying hands.

May 7, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences CEO Kevin Conroy will make the company's presentation at the Baird Growth Stock, JMP Securities Research and Bank of America Merrill Lynch Health Care Conferences during May.

May 7, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. to Report First Quarter 2012 Financial Results on May 9

May 7, 2012

PHILADELPHIA--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole...

May 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert Perez, EVP and COO of Cubist, will present on Tuesday May 15th, 2012, at 4:20 p.m. PT, at the Bank of America Merrill Lynch 2012 Health...

May 7, 2012

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--clinicalRSVP recently contributed key insight on subject registries at the 21st Annual Association of Clinical Pharmacology Units (ACPU) Meeting held at the National Institutes of Health (NIH).

May 7, 2012

HORSHAM, Pa.--(BUSINESS WIRE)--Dean Kamen will lead DIA’s meeting with the goal of fostering partnerships that may lead to promising concepts and research into new patient therapies.

May 7, 2012

DANVERS, Mass.--(BUSINESS WIRE)--NeuroLogica Corporation and German based MEYTEC GmbH announced today the development of the world’s first comprehensive mobile stroke ambulance. Stroke-Emergency-Mobile, VIMED® STEMO, combines MEYTEC’s cutting-...

May 7, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Octagon, announced it has been named 2012 Emerging Life Sciences Company of the Year by the Greater Philadelphia Alliance for Capital and Technologies (PACT).

May 7, 2012

GRAND FORKS, N.D.--(BUSINESS WIRE)--NovaDigm today presented Phase 1 data demonstrating that a single dose of NDV-3 with or without alum adjuvant was safe, well-tolerated and induced strong antibody and T-cell immune responses.

May 7, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Promedior announced that data from preclinical studies of Pentraxin-2 (PTX-2) were presented yesterday at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

May 7, 2012

FAIRFAX, Va.--(BUSINESS WIRE)--National Institutes of Health (NIH) NIAID awards five-year onsite management contract to SoBran for AAALAC laboratory facilities, including at the Comparative Medicine Branch (CMB).

May 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm today announced it can now offer unrestricted sales of its digital PCR to customers interested in pursuing research into the prenatal health and non-invasive prenatal diagnostics fields.

May 7, 2012

WEST ORANGE, N.J.--(BUSINESS WIRE)--ZRG Partners releases Q1 2012 Global Life Sciences hiring index. 4% increase in Q1.